{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:12:59Z","timestamp":1785442379998,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.001784","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T20:50:18Z","timestamp":1695934218000},"page":"376-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats"],"prefix":"10.1016","volume":"388","author":[{"given":"Donna A.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-5993","authenticated-orcid":false,"given":"Caroline R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"de Araujo Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Niquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude G.","family":"Wasterlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille A.","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001784_bib1","series-title":"Medical Aspects of Chemical Warfare","first-page":"221","article-title":"Neuroprotection as a treatment for nerve agent survivors","author":"Ballough","year":"2008"},{"key":"10.1124\/jpet.123.001784_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/WCO.0b013e32833735cf","article-title":"Neurosteroids and epilepsy","volume":"23","author":"Biagini","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1124\/jpet.123.001784_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2011.00050","article-title":"Neuroprotective actions of neurosteroids","volume":"2","author":"Borowicz","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/jpet.123.001784_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.123.001784_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2015.03.035","article-title":"Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures","volume":"95","author":"Bruun","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001784_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneumeth.2009.07.020","article-title":"Analyzing large data sets acquired through telemetry from rats exposed to organophosphorus compounds: an EEG study","volume":"184","author":"de Araujo Furtado","year":"2009","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.123.001784_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12996","article-title":"Allopregnanolone: an overview on its synthesis and effects","volume":"34","author":"Diviccaro","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/jpet.123.001784_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1124\/jpet.123.001784_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/75.6.816","article-title":"The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics","volume":"75","author":"Hsu","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.1124\/jpet.123.001784_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128313","article-title":"Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer\u2019s disease","volume":"10","author":"Irwin","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001784_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s40265-022-01724-0","article-title":"Ganaxolone: first approval","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"key":"10.1124\/jpet.123.001784_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/sleep\/20.12.1099","article-title":"The GABA(A) agonist THIP increases non-REM sleep and enhances non-REM sleep-specific delta activity in the rat during the dark period","volume":"20","author":"Lancel","year":"1997","journal-title":"Sleep"},{"key":"10.1124\/jpet.123.001784_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108444","article-title":"Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors","volume":"185","author":"Lumley","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001784_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/epi4.12552","article-title":"Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats","volume":"6","author":"Lumley","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1124\/jpet.123.001784_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104629","article-title":"Dataset of EEG power integral, spontaneous recurrent seizure and behavioral responses following combination drug therapy in soman-exposed rats","volume":"27","author":"Lumley","year":"2019","journal-title":"Data Brief"},{"key":"10.1124\/jpet.123.001784_bib16","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/epi.14582","article-title":"Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam","volume":"59","author":"Marrero-Rosado","year":"2018","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001784_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107229","article-title":"Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice","volume":"111","author":"Marrero-Rosado","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.123.001784_bib18","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/ijms22041893","article-title":"Novel genetically modified mouse model to assess soman-induced toxicity and medical countermeasure efficacy: human acetylcholinesterase knock-in serum carboxylesterase knockout mice","volume":"22","author":"Marrero-Rosado","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001784_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001784_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002040050637","article-title":"Comparative evaluation of benzodiazepines for control of soman-induced seizures","volume":"73","author":"McDonough","year":"1999","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.123.001784_bib21","first-page":"179","article-title":"Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition","volume":"8","author":"McDonough","year":"1986","journal-title":"Neurobehav Toxicol Teratol"},{"key":"10.1124\/jpet.123.001784_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2010.11.022","article-title":"Impaired auditory and contextual fear conditioning in soman-exposed rats","volume":"98","author":"Moffett","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.123.001784_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuro.2004.07.011","article-title":"Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance","volume":"26","author":"Myhrer","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.123.001784_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.123.001784_bib25","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001784_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/CPJ.0000000000000641","article-title":"Therapy for acute nerve agent poisoning: an update","volume":"9","author":"Newmark","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"10.1124\/jpet.123.001784_bib27","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001784_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.123.001784_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.06.011","article-title":"Early polytherapy for benzodiazepine-refractory status epilepticus","volume":"101","author":"Niquet","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.123.001784_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1060028019873320","article-title":"Brexanolone (Zulresso): finally, an FDA-approved treatment for postpartum depression","volume":"54","author":"Powell","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.123.001784_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0013-4694(73)90024-2","article-title":"First trial motor seizures triggered by amygdaloid stimulation in the rat","volume":"35","author":"Racine","year":"1973","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/jpet.123.001784_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status Epilepticus","volume":"15","author":"Rai","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.123.001784_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13160","article-title":"Neurosteroids for the potential protection of humans against organophosphate toxicity","volume":"1378","author":"Reddy","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001784_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/epi.14693","article-title":"Extrasynaptic \u03b3-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures","volume":"60","author":"Reddy","year":"2019","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001784_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol Sci"},{"issue":"0 6, Suppl 6","key":"10.1124\/jpet.123.001784_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001784_bib37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.118.252155","article-title":"Intravenously administered ganaxolone blocks diazepam-resistant lithium-pilocarpine-induced status epilepticus in rats: comparison with allopregnanolone","volume":"368","author":"Saporito","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001784_bib38","doi-asserted-by":"crossref","first-page":"24988","DOI":"10.1038\/srep24988","article-title":"Spatiotemporal profile of Map2 and microglial changes in the hippocampal CA1 region following pilocarpine-induced status epilepticus","volume":"6","author":"Schartz","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.123.001784_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pneurobio.2013.09.003","article-title":"The role of allopregnanolone in depression and anxiety","volume":"113","author":"Sch\u00fcle","year":"2014","journal-title":"Prog Neurobiol"},{"key":"10.1124\/jpet.123.001784_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ntt.2014.06.002","article-title":"Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats","volume":"44","author":"Schultz","year":"2014","journal-title":"Neurotoxicol Teratol"},{"key":"10.1124\/jpet.123.001784_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.taap.2012.01.017","article-title":"The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam","volume":"259","author":"Schultz","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001784_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001784_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0149-7634(05)80028-4","article-title":"Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms","volume":"15","author":"Shih","year":"1991","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.123.001784_bib44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/acn3.408","article-title":"First-in-man allopregnanolone use in super-refractory status epilepticus","volume":"4","author":"Vaitkevicius","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1124\/jpet.123.001784_bib45","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/epi.17343","article-title":"Intravenous ganaxolone for the treatment of refractory status epilepticus: results from an open-label, dose-finding, phase 2 trial","volume":"63","author":"Vaitkevicius","year":"2022","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001784_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3389\/fneur.2017.00700","article-title":"Status epilepticus triggers time-dependent alterations in microglia abundance and morphological phenotypes in the hippocampus","volume":"8","author":"Wyatt-Johnson","year":"2017","journal-title":"Front Neurol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:11:18Z","timestamp":1743199878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171728"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001784","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}